ORIGINAL
Persistencia en el tratamiento según el tipo de dispositivo inhalador en pacientes con asma y enfermedad pulmonar obstructiva crónica
Persistence to treatment by type of inhaler device in patients with asthma and chronic obstructive pulmonary disease
a CAP Vicenç Papaciet, La Roca del Vallès (Barcelona), España
b Departamento Médico, Mundipharma, Madrid, España
c Documentación Médica, Hospital Germans Trias i Pujol, Badalona (Barcelona), España
d Research Group on Statistics, Econometrics and Health (GRECS), Universidad de Girona, Girona, España
e CIBER Epidemiología/Salud Pública (CIBERESP), Madrid, España
Leído
6636
Vecesse ha leído el artículo
1432
Total PDF
5204
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 14 | 5 | 19 |
| 2025 11 | 92 | 34 | 126 |
| 2025 10 | 74 | 15 | 89 |
| 2025 9 | 57 | 23 | 80 |
| 2025 8 | 48 | 18 | 66 |
| 2025 7 | 73 | 19 | 92 |
| 2025 6 | 57 | 10 | 67 |
| 2025 5 | 44 | 7 | 51 |
| 2025 4 | 40 | 14 | 54 |
| 2025 3 | 56 | 7 | 63 |
| 2025 2 | 45 | 14 | 59 |
| 2025 1 | 39 | 5 | 44 |
| 2024 12 | 31 | 3 | 34 |
| 2024 11 | 18 | 5 | 23 |
| 2024 10 | 40 | 6 | 46 |
| 2024 9 | 33 | 6 | 39 |
| 2024 8 | 35 | 13 | 48 |
| 2024 7 | 19 | 4 | 23 |
| 2024 6 | 28 | 5 | 33 |
| 2024 5 | 42 | 6 | 48 |
| 2024 4 | 46 | 12 | 58 |
| 2024 3 | 60 | 6 | 66 |
| 2024 2 | 74 | 8 | 82 |
| 2024 1 | 70 | 9 | 79 |
| 2023 12 | 48 | 3 | 51 |
| 2023 11 | 57 | 9 | 66 |
| 2023 10 | 54 | 5 | 59 |
| 2023 9 | 41 | 3 | 44 |
| 2023 8 | 19 | 4 | 23 |
| 2023 7 | 38 | 8 | 46 |
| 2023 6 | 36 | 7 | 43 |
| 2023 5 | 43 | 8 | 51 |
| 2023 4 | 26 | 4 | 30 |
| 2023 3 | 67 | 18 | 85 |
| 2023 2 | 49 | 8 | 57 |
| 2022 1 | 38 | 3 | 41 |
| 2022 12 | 32 | 10 | 42 |
| 2022 11 | 36 | 11 | 47 |
| 2022 10 | 52 | 41 | 93 |
| 2022 9 | 45 | 22 | 67 |
| 2022 8 | 34 | 20 | 54 |
| 2022 7 | 35 | 12 | 47 |
| 2022 6 | 51 | 10 | 61 |
| 2022 5 | 65 | 14 | 79 |
| 2022 4 | 81 | 7 | 88 |
| 2022 3 | 150 | 13 | 163 |
| 2022 2 | 150 | 12 | 162 |
| 2021 1 | 130 | 13 | 143 |
| 2021 12 | 91 | 21 | 112 |
| 2021 11 | 89 | 17 | 106 |
| 2021 10 | 41 | 21 | 62 |
| 2021 9 | 26 | 12 | 38 |
| 2021 8 | 24 | 14 | 38 |
| 2021 7 | 59 | 13 | 72 |
| 2021 6 | 35 | 6 | 41 |
| 2021 5 | 48 | 12 | 60 |
| 2021 4 | 121 | 23 | 144 |
| 2021 3 | 39 | 17 | 56 |
| 2021 2 | 72 | 12 | 84 |
| 2020 1 | 42 | 12 | 54 |
| 2020 12 | 46 | 14 | 60 |
| 2020 11 | 29 | 20 | 49 |
| 2020 10 | 14 | 12 | 26 |
| 2020 9 | 20 | 13 | 33 |
| 2020 8 | 27 | 17 | 44 |
| 2020 7 | 26 | 17 | 43 |
| 2020 6 | 36 | 18 | 54 |
| 2020 5 | 34 | 16 | 50 |
| 2020 4 | 41 | 12 | 53 |
| 2020 3 | 49 | 13 | 62 |
| 2020 2 | 43 | 17 | 60 |
| 2020 1 | 48 | 11 | 59 |
| 2019 12 | 42 | 13 | 55 |
| 2019 11 | 44 | 10 | 54 |
| 2019 10 | 29 | 13 | 42 |
| 2019 9 | 51 | 13 | 64 |
| 2019 8 | 23 | 7 | 30 |
| 2019 7 | 37 | 12 | 49 |
| 2019 6 | 62 | 14 | 76 |
| 2019 5 | 242 | 28 | 270 |
| 2019 4 | 91 | 31 | 122 |
| 2019 3 | 32 | 16 | 48 |
| 2019 2 | 53 | 23 | 76 |
| 2019 1 | 55 | 15 | 70 |
| 2018 12 | 48 | 20 | 68 |
| 2018 11 | 91 | 28 | 119 |
| 2018 10 | 123 | 19 | 142 |
| 2018 9 | 113 | 17 | 130 |
| 2018 8 | 94 | 13 | 107 |
| 2018 7 | 32 | 11 | 43 |
| 2018 6 | 35 | 17 | 52 |
| 2018 5 | 49 | 17 | 66 |
| 2018 4 | 42 | 4 | 46 |
| 2018 3 | 39 | 4 | 43 |
| 2018 2 | 33 | 9 | 42 |
| 2018 1 | 21 | 10 | 31 |
| 2017 12 | 5 | 1 | 6 |
| 2017 11 | 7 | 0 | 7 |
| 2017 10 | 3 | 0 | 3 |
| 2017 9 | 7 | 2 | 9 |
| 2017 8 | 12 | 11 | 23 |
| 2017 7 | 34 | 6 | 40 |
| 2017 6 | 11 | 19 | 30 |
| 2017 5 | 6 | 17 | 23 |
| 2017 4 | 1 | 7 | 8 |
| 2017 3 | 5 | 23 | 28 |
| 2017 2 | 1 | 24 | 25 |
| 2016 1 | 0 | 8 | 8 |
| 2016 12 | 7 | 19 | 26 |
| 2016 11 | 0 | 13 | 13 |
| 2016 10 | 8 | 19 | 27 |
| 2016 9 | 2 | 11 | 13 |
| 2016 8 | 1 | 5 | 6 |
| 2016 7 | 1 | 4 | 5 |
Mostrar todo
